image: In a prospective cohort study, Kai Qin and colleagues expose the progressive decline of adaptive immune functions in chronic lymphocytic leukemia patients following SARS-CoV-2 mRNA vaccination. view more
Credit: Randall Davis (CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)
Progressively declining immune functions in individuals with chronic lymphocytic leukemia revealed by prospective study of immune responses to COVID vaccines between December 2020 and June 2021
#####
In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004157
Article Title: Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study
Author Countries: United States
Funding: These studies were funded in part by the UAB School of Medicine Dean’s office COVID-19 research initiative (BML, PAG, and RSD) (https://www.uab.edu/medicine/home/research/covid-19-research), the UAB Cancer Immunobiology Program (RSD), and grants from the NIAID/NIH UM1AI069452 (PAG), NIAID/NIH R01AI150590 (BHH), and NCI/NIH U01CA260462 (RSD) (https://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Journal
PLOS Medicine
COI Statement
Competing interests: The authors have declared that no competing interests exist.